Baseline variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95%CI | p Value | Hazard ratio | 95%CI | p Value | |
Age, years | 1.08 | (1.02–1.14) | 0.006 | 1.08 | (1.02–1.14) | 0.009 |
Male | 2.46 | (1.25–4.83) | 0.009 | 2.38 | (1.10–5.13) | 0.027 |
BMI (kg/m2) | 0.93 | (0.85–1.02) | 0.143 |  |  |  |
Hypertension | 0.56 | (0.27–1.19) | 0.132 |  |  |  |
Diabetes | 1.19 | (0.57–2.45) | 0.650 |  |  |  |
Alcohol use disorder | 2.65 | (1.28–5.47) | 0.009 |  |  |  |
Antiviral regimen | ||||||
PEG ± RBV |  | Reference |  |  |  |  |
DAA | 2.77 | (1.24–6.20) | 0.013 |  |  |  |
PR + DAA | 1.67 | (0.58–4.81) | 0.343 |  |  |  |
Platelets (× 109/L) | 0.99 | (0.99–1.00) | 0.004 |  |  |  |
ALT (IU/L) | 1.00 | (1.00–1.01) | 0.662 |  |  |  |
Albumin (g/L) | 0.89 | (0.84–0.93) |  < 0.001 | 0.92 | (0.86–1.00) | 0.037 |
Bilirubin (µmol/L) | 1.03 | (1.02–1.05) |  < 0.001 |  |  |  |
INR | 18.82 | (4.78–74.29) |  < 0.001 |  |  |  |
Alpha-fetoprotein (ng/mL) | 1.01 | (0.99–1.02) | 0.408 |  |  |  |
LSM (kPa) | 1.05 | (1.03–1.07) |  < 0.001 | 1.03 | (1.01–1.06) | 0.001 |
Delta-LSM (kPa) | 1.04 | (1.01–1.08) | 0.022 |  |  |  |
FIB-4 score | 1.10 | (1.06–1.15) |  < 0.001 |  |  |  |
Delta-FIB-4 score | 1.14 | (1.07–1.21) |  < 0.001 |  |  |  |